Oligomer array with pna and/or dna oligomers on a surface
CA 2390312 C · Owner: Epigenomics Ag · Inventors: Berlin, Kurt
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to an oligomer array with PNA (Peptide Nucleic Acid) and/or DNA oligomers on a surface, said oligomers comprising oligomers of 6 to 20 monomers or nucleobases each. Said monomers or nucleobases comprise at least one sequence of the general formula DDCGDD or of the general formula DDTGDD or of the general formula HHCGHH or of the general formula HHCAHH wherein H represents any of the bases adenine (A) cytosine (C) or thymine (T) , and D represents any of the bases adenine (A) guanine (G) or thymine (T). The , location of the oligomers on the surface is correlated with the sequence of the oligomers. The inventive oligomer arrays are used to detect cytosine …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 24, 2000 and granted May 31, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended November 24, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 24, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.